Related Experiment Video
Updated: Aug 5, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Combined Apocynin and Novokinin Treatment Attenuates Renal Damage and Reduces KIM-1 Expression in a Model of Ischemic
Milan Ivanov1, Nevena Mihailović-Stanojević1, Una-Jovana Vujačić1
1Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Dr Subotića 4, 11000 Belgrade, Serbia.
Abstract:
Ischemia-reperfusion injury (IRI) of the kidney represents a serious medical issue with complex pathological mechanisms that remain poorly elucidated. The development of ischemic acute kidney injury (AKI) may be mediated by NADPH oxidase and angiotensin II type 2 receptors. The aim of our study was to explore the effects of novokinin (NOV), angiotensin II type 2 receptor (AT2R) agonist and apocynin (APO), an NADPH oxidase inhibitor, on kidney structure and function, as well as the level of oxidative stress in spontaneously hypertensive rats (SHR) with induced IRI. Animals were randomly assigned into five experimental groups: the Sham-operated animals (SHAM) group, the AKI group, and AKI groups receiving APO, NOV, or their combination. Slight improvements in renal function were noted across all treated groups; however, only the combined action of APO + NOV led to a significant decrease in kidney injury molecule-1 (KIM-1) levels and markedly reduced oxidative stress compared with the control AKI group. Our results demonstrate that additively targeting NADPH oxidase and AT2R provides new insights in comparison to individual treatments. These findings suggest a potentially promising new therapeutic strategy for managing IRI and improving outcomes in critically ill patients with AKI.
Insights
Targeting both NADPH oxidase and angiotensin II type 2 receptors may offer a promising therapeutic strategy for kidney ischemia-reperfusion injury (IRI). Combined treatment significantly reduced kidney injury and oxidative stress in a rat model.
Area of Science:
- Nephrology
- Cardiovascular Research
- Oxidative Stress
Background:
- Kidney ischemia-reperfusion injury (IRI) is a significant clinical challenge with incompletely understood mechanisms.
- NADPH oxidase and angiotensin II type 2 receptors (AT2R) are implicated in the pathogenesis of ischemic acute kidney injury (AKI).
Purpose of the Study:
- To investigate the therapeutic effects of apocynin (APO), an NADPH oxidase inhibitor, and novokinin (NOV), an AT2R agonist, on kidney IRI in spontaneously hypertensive rats (SHR).
- To evaluate the combined efficacy of APO and NOV in mitigating kidney damage and oxidative stress.
Main Methods:
- Spontaneously hypertensive rats (SHR) underwent induced kidney IRI and were divided into five groups: Sham-operated, AKI, and AKI treated with APO, NOV, or both.
- Renal function, kidney injury molecule-1 (KIM-1) levels, and oxidative stress markers were assessed.
Main Results:
- All treatments showed slight improvements in renal function.
- The combination of APO and NOV significantly reduced KIM-1 levels and oxidative stress compared to the control AKI group.
- Additive effects were observed when targeting both NADPH oxidase and AT2R.
Conclusions:
- Combined inhibition of NADPH oxidase and AT2R activation offers superior therapeutic benefits for kidney IRI than individual treatments.
- This dual-targeting strategy presents a potentially promising approach for managing AKI in critically ill patients.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Acute Kidney Injury V: Interprofessional Care
Antihypertensive Drugs: Direct Renin Inhibitors
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction
